Prbenlysta (belimumab) - Increased Risk Of Serious Depression, Suicidal Ideation Or Behaviour, Or Self-injury

Benlysta (belimumab), a medication used to treat lupus and other autoimmune conditions, is being recalled in Canada because it carries an increased risk of serious depression, suicidal thoughts, or self-harm. The medication has been distributed across Canada. This safety issue affects all patients currently taking or who may take this drug.

Reason

Product safety

Category

drug recall

Country

Canada

Agency

HC-DRUGS

Recall date

2019-04-04

Status

Ongoing

Distribution

Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/b3359e67-2b74-45f7-a229-78bc7d9faaed